2m 2m 2m 2m 2m 2m 2m
Onconetix (ONCO)
NASDAQ
$3.71-$0.05 (-1.33%)
Price as of Nov 12, 2026 8:26 AM EST- $22.1MMarket Cap
- -99.73%1-Year Change
- BiotechnologyIndustry
Onconetix (ONCO)
$3.71-$0.05 (-1.33%)
ONCO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.76 | ||
Change | +$0.29 (+8.36%) | ||
Open | $3.49 | ||
High | $3.80 | ||
Low | $3.45 | ||
Previous Close | $3.47 | ||
Volume | 73,147 | ||
30-Day Average Volume | 358,939 | ||
1-Week Change | -42.88% | ||
1-Month Change | -39.35% | ||
1-Year Change | -99.73% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 5.9M | ||
Total Assets | $16.4M | ||
Market Cap | $22.1M | ||
Enterprise Value | $20.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$1.9M | ||
EBIT | -$2.9M | ||
EBITDA | -$2.9M | ||
Net Working Capital | $3.6M | ||
EPS | -$12.80 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 11/06/2026 | ||
Earnings & Revenue